Abrdn Healthcare InvestorsHQH.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, Abrdn Healthcare Investors (HQH.N) trades at a P/E of N/A, P/B of 0.95x, P/S of N/A, and a dividend yield of 10.02%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B sits at the 58th percentile over the trailing 10Y window (vs. 58th percentile over 3Y); P/S historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data).
Cross-sectional valuation: its P/B ranks at the 89th percentile within its industry and the 28th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 10.02%, ranking at the 87th percentile over the trailing 20Y window.
The P/B percentile sits lower across the market than within its own industry — relatively cheaper next to the market as a whole. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Abrdn Healthcare Investors operates in the other sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: HQH · HQH
Want the full picture on whether Abrdn Healthcare Investors (HQH.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | N/A | — | — | — | — | — | — |
| P/B (MRQ) | 0.95 | ||||||
| P/S (TTM) | N/A | — | — | — | — | — | — |
| Dividend Yield | 10.02% | ||||||
| Buyback + Div Yield | 10.02% |